1-3 of 3
Daniel Freigeiro, MD
Close
Sort by
Journal Articles

Comparison of Outcome of Adolescents with Newly Diagnosed Hodgkin Lymphoma (HL) in Argentina, Treated within a Pediatric Vs an Adults Clinical Trial : Experience of the Gatla Group

David Alejandro Veron, MD, Patricia Streitenberger, MD, Daniel Freigeiro, MD, Astrid Pavlovsky, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5175.
https://doi.org/10.1182/blood.V130.Suppl_1.5175.5175
Published: 2017
Journal Articles

Clofarabine in Pediatric Patients with Refractory or Relapsed Leukemia: the GATLA experience.

David Veron, MD, Cecilia Riccheri, MD, Monica Makiya, MD, Luis Alberto Aversa, MD, Marcela Gutierrez, MD, Alcira Fynn, MD, Virginia Schuttenberg, MD, Alejandra CeĢdola, MD, Constanza Drozdowski, MD, Horacio Caferri, MD, Julieta Bietti, MD, Sergio Gomez, MD, Graciela Onelda Elena, MD, Guillermo Arbesu, MD, Carlos Hollmann, MD, Bibiana Tramunt, MD, Mercedes Tomasetti, MD, Sandra Zirone, MD, Nestor Rossi, MD, Daniel Freigeiro, MD
Journal: Blood
Blood (2012) 120 (21): 2605.
https://doi.org/10.1182/blood.V120.21.2605.2605
Published: 2012
Journal Articles

Management of Hereditary Spherocytosis in a Public Health Care Provider in a Developing Country.

Leonardo Feldman, MD, Guillermo Drelichman, MD, Nora Basack, MD, Ernesto Rodriguez, MD, Daniel Freigeiro, MD, Luis Aversa, MD
Journal: Blood
Blood (2005) 106 (11): 3752.
https://doi.org/10.1182/blood.V106.11.3752.3752
Published: 2005